The recent authorization by the FDA of the inaugural gene therapy for genetic-related hearing impairment signifies a ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...

Otarmeni, a surgically-delivered drug developed by Regeneron, recently received accelerated FDA approval to treat a rare, ...

Four decades have passed since cochlear implants gave infants born deaf the ability to hear. Now, gene therapy promises to restore natural hearing for those born with a rare form of deafness, and the ...

The Allen Institute in Seattle says scientists have now learned enough about how the brain works to start fixing it when it ...

Cell and gene therapy encompasses a broad range of therapeutic interventions for diseases that have proved refractory to treatment with conventional pharmaceutical approaches. Perhaps the most ...

The special properties of methylcellulose foam could make it a vehicle for bedside genetic engineering, according to a proof-of-principle study from bioengineers at Fred Hutch Cancer Center. In the ...

In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in people with difficult-to-treat lipid disorders, ...

Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared ...

This sponsored article was provided by a partner and is not editorial content from Los Angeles Magazine or the Engine Vision Media Network. Every cell in your body holds a unique genetic code within ...

“GLP-1 medicines have changed what is possible in obesity and Type 2 diabetes," Dr. Harith Rajagopalan said.